eClinical Tech News

NovelMed’s Ruxoprubart, a novel complement-targeting immunotherapy, has shown positive interim results in a Phase II trial for Paroxysmal Nocturnal...

Prime Medicine announced positive initial clinical trial data for PM359, a prime-edited cell therapy for Chronic Granulomatous Disease (CGD)....

Excision BioTherapeutics announced preclinical data demonstrating the efficacy of EBT-107, a CRISPR-based gene therapy candidate for chronic hepatitis B...

Pacira BioSciences announced preliminary data suggesting that pre-existing and treatment-induced antibodies do not impact the safety and efficacy of...

Voyager Therapeutics published data in Molecular Therapy demonstrating the ability of alkaline phosphatase (ALPL) to transport a novel AAV...

BioCryst Pharmaceuticals announced real-world evidence demonstrating significant and sustained reductions in HAE attack rates for adolescents and individuals with...

Tectonic Therapeutic announced complete results from Part A of its Phase 1b clinical trial of TX45 for Group 2...

Silo Pharma (Nasdaq: SILO), a biopharmaceutical company developing novel therapeutics and drug delivery systems, has partnered with Veloxity Labs...

Vaxart announced complete Phase 2b results for its oral norovirus vaccine candidate, demonstrating safety and efficacy against infection. The...

MeiraGTx Holdings plc will present four posters at the 2025 ASGCT Annual Meeting, showcasing advancements in gene therapy for...